SpunkySkunk347
Bluelighter
- Joined
- Jan 15, 2006
- Messages
- 1,717
Amphetamine achieves most of its effects by blocking and reversing the reuptake of dopamine, norepinephrine, and serotonin. This causes these neurotransmitters to be released into the synapse, as well as to be "stuck in the synapse" (I believe until the neurotransmitters are metabolized by monoamine oxidase). Since amphetamine is blocking the reuptake, dopamine is unable to be re-packaged into the presynaptic neuron for future use, resulting in low dopamine levels.
Amphetamine releases dopamine in neural pathways where dopamine is primarily responsible for psychological "motivation" - psychologically, dopamine allows for the ideas of "possible actions" to be converted into real actions. Dopamine is responsible for the "desire" for a particular action be completed, and hence the observed effect is increased motivation.
The delusionality observed in particular cases of amphetamine use (especially prolonged usage or with high doses) can be theorized as the result of a psychological "overly estimated significance" of a possible action. In other words, an amphetamine user thinks that what's going on around him is more important than it actually is.
When our brain is deciding what responses to give to various stimuli, dopamine increases the likelihood of such responses occurring through increased motivation. The desire to produce a response is escalated; the neuronal signals are much stronger than what they actually would be if the individual was not on amphetamine.
Another key neurotransmitter responsible for delusionality is norepinephrine. Norepinephrine increases (both consciously and subconsciously) our awareness of the environment around us. Norepinephrine is also released in significant amounts by amphetamine.
The result is, the amphetamine user receives an excessive amount of incoming stimulation of the surrounding environment (due to norepinephrine), and the stimulus is determined to be significant enough to produce a response (due to dopamine).
Paranoia can easily result. A chain reaction can occur where norepinephrine levels continuously increase. This happens when a stimulation is accompanied by fear, and the desire to respond to a stimulation is also accompanied by a signal to release more norepinephrine (as well as epinephrine) - causing for more stimulation to be received and "over perceived" from dopamine levels, and this can in many cases cause a perpetual panic attack.
However, amphetamine also releases serotonin. The serotonin released can indirectly produce an inhibitory response to dopamine-pathways (and partially norepinephrine). This is where "mind over matter" comes in. When a person is experiencing paranoia and realizes it is merely all in their head and says to themself "Hey, everything is going to be alright, its all in my head", serotonin is the key neurotransmitter responsible. Dopamine-pathways are inhibited and serotonin can furthermore provoke the release of endorphins to cause a sense of comfort and relaxation.
This also explains why methamphetamine (which releases higher amounts of serotonin) is perceived to be more pleasurable than amphetamine, especially in users who already have pre-existing anxiety (suggesting pre-existing low serotonin levels).
From this we can conclude that dopamine does not cause pleasure, it causes desire. It is serotonin's inhibitory effects on dopamine-pathways and the indirect release of endorphins that is responsible for amphetamine's pleasurable effects.
Amphetamines During SSRI Withdrawals
Upon the discontinuation of SSRIs (zoloft, paxil, etc) serotonin levels in the brain drop to an incredibly low amount. Not only this, but the impact made from the little remaining serotonin is mitigated due to our brains desensitization of endogenous serotonin (because of the increased serotonin levels while the SSRI was still in use).
The result is, there is no longer enough serotonin to effectively inhibit dopamine-pathways. This causes the symptoms of anxiety, paranoia, delusionality, agitation, disassociation, and depression.
If amphetamine is administered during SSRI discontinuation, the results can be horrific.
I experienced this first hand while discontinuing Zoloft 200mg/day yet still taking Adderall 60mg/day. I entered a psychosis, and this was before I came to the realization that discontinuing my zoloft was the cause of my psychosis.
Pleasure in my life was completely non-existent during this time, and I can't even imagine the amount of neurological damage I have done as a result.
Among the symptoms of psychosis, I also experienced a large amount of "deja vu" (which has been attributed by neurologists to an excessive amount of dopamine). I also suffered from severe amnesia, and much of my psychosis is absent from my memory (amnesia is commonly experienced during trauma).
Amphetamine "Crash"
When dopamine levels become depleted after the use of amphetamine, norepinephrine levels are still at a high. This causes an excess of stimulation to be received (due to NE) but no motivation for a response (due to depleted DA). The effect is agitation, anxiety, restlessness, and oversensitivity to incoming stimulation.
References:
Amphetamine Depresses Excitatory Synaptic Transmission via Serotonin Receptors in the Ventral Tegmental Area
http://www.jneurosci.org/cgi/content/full/19/22/9780
Balance between Dopamine and Serotonin Release Modulates Behavioral Effects of Amphetamine-Type Drugs
http://www3.interscience.wiley.com/journal/120175749/abstract
Amphetamine releases dopamine in neural pathways where dopamine is primarily responsible for psychological "motivation" - psychologically, dopamine allows for the ideas of "possible actions" to be converted into real actions. Dopamine is responsible for the "desire" for a particular action be completed, and hence the observed effect is increased motivation.
The delusionality observed in particular cases of amphetamine use (especially prolonged usage or with high doses) can be theorized as the result of a psychological "overly estimated significance" of a possible action. In other words, an amphetamine user thinks that what's going on around him is more important than it actually is.
When our brain is deciding what responses to give to various stimuli, dopamine increases the likelihood of such responses occurring through increased motivation. The desire to produce a response is escalated; the neuronal signals are much stronger than what they actually would be if the individual was not on amphetamine.
Another key neurotransmitter responsible for delusionality is norepinephrine. Norepinephrine increases (both consciously and subconsciously) our awareness of the environment around us. Norepinephrine is also released in significant amounts by amphetamine.
The result is, the amphetamine user receives an excessive amount of incoming stimulation of the surrounding environment (due to norepinephrine), and the stimulus is determined to be significant enough to produce a response (due to dopamine).
Paranoia can easily result. A chain reaction can occur where norepinephrine levels continuously increase. This happens when a stimulation is accompanied by fear, and the desire to respond to a stimulation is also accompanied by a signal to release more norepinephrine (as well as epinephrine) - causing for more stimulation to be received and "over perceived" from dopamine levels, and this can in many cases cause a perpetual panic attack.
However, amphetamine also releases serotonin. The serotonin released can indirectly produce an inhibitory response to dopamine-pathways (and partially norepinephrine). This is where "mind over matter" comes in. When a person is experiencing paranoia and realizes it is merely all in their head and says to themself "Hey, everything is going to be alright, its all in my head", serotonin is the key neurotransmitter responsible. Dopamine-pathways are inhibited and serotonin can furthermore provoke the release of endorphins to cause a sense of comfort and relaxation.
This also explains why methamphetamine (which releases higher amounts of serotonin) is perceived to be more pleasurable than amphetamine, especially in users who already have pre-existing anxiety (suggesting pre-existing low serotonin levels).
From this we can conclude that dopamine does not cause pleasure, it causes desire. It is serotonin's inhibitory effects on dopamine-pathways and the indirect release of endorphins that is responsible for amphetamine's pleasurable effects.
Amphetamines During SSRI Withdrawals
Upon the discontinuation of SSRIs (zoloft, paxil, etc) serotonin levels in the brain drop to an incredibly low amount. Not only this, but the impact made from the little remaining serotonin is mitigated due to our brains desensitization of endogenous serotonin (because of the increased serotonin levels while the SSRI was still in use).
The result is, there is no longer enough serotonin to effectively inhibit dopamine-pathways. This causes the symptoms of anxiety, paranoia, delusionality, agitation, disassociation, and depression.
If amphetamine is administered during SSRI discontinuation, the results can be horrific.
I experienced this first hand while discontinuing Zoloft 200mg/day yet still taking Adderall 60mg/day. I entered a psychosis, and this was before I came to the realization that discontinuing my zoloft was the cause of my psychosis.
Pleasure in my life was completely non-existent during this time, and I can't even imagine the amount of neurological damage I have done as a result.
Among the symptoms of psychosis, I also experienced a large amount of "deja vu" (which has been attributed by neurologists to an excessive amount of dopamine). I also suffered from severe amnesia, and much of my psychosis is absent from my memory (amnesia is commonly experienced during trauma).
Amphetamine "Crash"
When dopamine levels become depleted after the use of amphetamine, norepinephrine levels are still at a high. This causes an excess of stimulation to be received (due to NE) but no motivation for a response (due to depleted DA). The effect is agitation, anxiety, restlessness, and oversensitivity to incoming stimulation.
References:
Amphetamine Depresses Excitatory Synaptic Transmission via Serotonin Receptors in the Ventral Tegmental Area
http://www.jneurosci.org/cgi/content/full/19/22/9780
Balance between Dopamine and Serotonin Release Modulates Behavioral Effects of Amphetamine-Type Drugs
http://www3.interscience.wiley.com/journal/120175749/abstract
Last edited:

